Clinical Trials Sponsored by International Pharmaceutical Consultancy

Total 148 results

International Pharmaceutical Consultancy

Withdrawn

Sensitivity and Specificity of the Modified Helicobacter Test INFAI

Dyspepsia | GERD

France
United Pharmaceuticals
Delta Consultants

Recruiting

Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation

Functional Constipation

Italy
Unither Pharmaceuticals, France
International Pharmaceutical Research Center

Completed

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

Healthy

Jordan
California Retina Consultants
Regeneron Pharmaceuticals

Completed

Variable Interval Versus Set Interval Aflibercept for DME (EVADE)

Diabetic Macular Edema | Cystoid Macular Edema

United States
Ophthalmic Consultants of Boston
Regeneron Pharmaceuticals

Completed

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (ANDROID)

Central Retinal Vein Occlusion | Proliferative Diabetic Retinopathy

United States
University of Maryland, Baltimore
D'Antonio Consultants International, Inc.

Completed

Safety Study of Seasonal Influenza Vaccine by Jet Injection

Healthy Adults

United States
EpiEndo Pharmaceuticals
CTC Clinical Trial Consultants AB

Completed

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

COPD | Chronic Obstructive Pulmonary Disease Exacerbation

Sweden
Minnesota Eye Consultants, P.A.
NovaBay Pharmaceuticals, Inc.

Terminated

Ocular Comfort and Inflammation in Lid Hygiene Therapy

Blepharitis

United States
University Diabetes & Endocrine Consultants
Amylin Pharmaceuticals, LLC.

Completed

A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes

IDDM

United States
Ophthalmic Consultants of Long Island
Regeneron Pharmaceuticals

Completed

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study (ACT)

Proliferative Diabetic Retinopathy

United States
Retina Consultants of Orange County
Regeneron Pharmaceuticals

Not yet recruiting

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Diabetic Macular Edema (DME)

United States
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Southern California Desert Retina Consultants, MC
Regeneron Pharmaceuticals

Completed

Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment (EVEN)

Submacular Vascularized Pigment Epithelial Detachments

United States
Ohr Pharmaceutical Inc.
Cumberland Valley Retina Consultants, PC

Completed

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion
NovaBay Pharmaceuticals, Inc.
Novum Pharmaceutical Research Services; International Dermatology Research,...

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Impetigo

Dominican Republic
Kiniksa Pharmaceuticals, Ltd.

Completed

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Arthritis, Rheumatoid

United States, Poland, Hungary, Georgia, Czechia, South Africa, Bulgaria
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals, GmbH

Recruiting

A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease

Sjögrens Disease

United States
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals, Ltd.

Completed

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

COVID

United States, Brazil, South Africa, Chile, Peru
International CTEPH Association
Janssen Pharmaceuticals

Recruiting

TrEatment Approach in the Multimodal Era Registry (TEAM)

Chronic Thromboembolic Pulmonary Hypertension | CTEPH

United States, Denmark, Belgium, Canada, Japan, Argentina, Italy, Czech Republic, Austria, Germany, Poland, India, Spain, Mexico, China, Brazil, Turkey, Singapore, Colombia, United Kingdom
Vitreous -Retina- Macula Consultants of New York
Regeneron Pharmaceuticals

Withdrawn

Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

Fibrovascular Pigment Epithelial Detachment

United States
Genzada Pharmaceuticals USA, Inc.
CTC Clinical Trial Consultants AB

Recruiting

Trial to Investigate GZ21T in Healthy Volunteers

Actinic Keratosis

Sweden
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals (UK), Ltd.

Recruiting

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients (RESONANCE)

Recurrent Pericarditis

United States
Mylan Inc.
Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.

Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

China
SRI International
Taiho Pharmaceutical Co., Ltd.

Completed

Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer

Breast Cancer

United States
Vitreous -Retina- Macula Consultants of New York
Regeneron Pharmaceuticals

No longer available

Use of Eylea for the Treatment of an Optic Nerve Hemangioma

Retinal Hemangioma

United States
Jeffrey S Heier
Regeneron Pharmaceuticals

Unknown

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD (PRO-CON)

Age-Related Macular Degeneration

United States
Jeffrey S Heier
Kato Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

Vitreomacular Traction | Vitreomacular Adhesion | Vitreomacular Attachment

United States
Mayo Clinic
Takeda Pharmaceuticals International, Inc.

Completed

Biomarkers for Intestinal Permeability in Patients With Constipation

Irritable Bowel Syndrome | Intestinal Diseases | Constipation

United States
Mahidol University
Takeda Pharmaceuticals International, Inc.

Completed

High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication

Dyspepsia | Helicobacter-associated Gastritis | Stomach Disorders

Thailand
International Biomedical Systems S.p.A.
CSC Pharmaceuticals

Unknown

Numen Stent Assessment Using OCT Technique in a Single Center Study (NAUTIC)

Hyperplasia | Restenosis

Austria
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; Clinical Research Consultants, Inc.; Clinical Research...

Active, not recruiting

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis (CKD)

Chronic Kidney Disease

Vietnam
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi (VITAL)

Invasive Fungal Infections | Aspergillosis

Korea, Republic of, United States, Belgium, Israel, Mexico, Canada, Brazil, Chile, Argentina, France, Thailand, Egypt, Australia, Germany, India, Lebanon, Poland, Russian Federation, South Africa
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Aspergillosis | Invasive Fungal Infection

Korea, Republic of, Belgium, Australia, United States, Germany, Switzerland, Israel, Canada, Argentina, Chile, Malaysia, Thailand, France, Russian Federation, Hungary, Spain, Brazil, China, India, Egypt, Italy, Turkey, Netherlands, Me... and more
University Hospital Muenster
Basilea Pharmaceutica International Ltd

Terminated

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus (AliCLE)

Lupus Erythematosus, Cutaneous

Germany
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers

Healthy Volunteers | Pharmacokinetics of BAL4815 | Pharmacokinetics of BAL8728

China
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Isavuconazole and Tacrolimus

Healthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Tacrolimus

United States
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Isavuconazole and Cyclosporine

Healthy

United States
Cheryl Rosenfeld, DO
Amylin Pharmaceuticals, LLC.

Unknown

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Abbott
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

Cardiovascular Diseases | Dyslipidemias | Hypertriglyceridemia

China
Abbott
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia

Elective Laparoscopic Surgery

China
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

HIV Infections

Belgium
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
GlaxoSmithKline
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief

Ankle Sprain

China
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

HIV Infections

Belgium
Galmed Pharmaceuticals Ltd
Hammersmith Medicines Research; Diamond Pharma Services Regulatory Affairs... and other collaborators

Completed

Comparison of Aramchol Concentrations With Once or Twice Daily Dosing

Healthy

United Kingdom
Korea University Guro Hospital
Takeda Pharmaceuticals International, Inc.

Terminated

Manidipine Versus Amlodipine in Patients With Hypertension

Hypertension

Korea, Republic of
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. (β-SPECIFIC 3)

Systemic Juvenile Idiopathic Arthritis

Italy, United States, Belgium, Germany, Greece, Russian Federation, Turkey, Spain, France, Israel, Canada, Hungary, Switzerland, United Kingdom, Brazil, Austria, Sweden, Netherlands, Argentina, Peru, Poland
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (β-SPECIFIC 2)

Systemic Juvenile Idiopathic Arthritis With Active Flare

United States, Argentina, Canada, Switzerland, Germany, Israel, South Africa, Belgium, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru

Clinical Trials Sponsored by International Pharmaceutical Consultancy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations